We finally evaluated the performance of the CCL20/LCN2-based model (model_2) in discriminating HCC from the comprehensive control that includes all nontumor subjects and the control of patients with liver cirrhosis, which constitutes the highest risk group for the development of HCC. This evidence concerns the gene CCL20 and hepatocellular carcinoma.